Outlook Therapeutics, Inc. (OTLK)

0.5466 -0.03 (-4.81%) USD  |  NASDAQ  |  Jan 13, 10:04
More

Outlook Therapeutics Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for OTLK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Neogen Corp. Upgrade
CorMedix, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade